# Exemestane (Exemestane)

Source: https://ourhealthnetwork.com/drugs/exemestane
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Exemestane?

Exemestane is an aromatase inhibitor. It is prescribed to treat breast neoplasms. Across the United States, 5,000 doctors prescribe Exemestane to approximately 22,000 Medicare patients.

## Brand names

Exemestane

## Indications

Exemestane is primarily prescribed for the treatment of breast neoplasms.

## Conditions treated

- [Breast Neoplasms](https://ourhealthnetwork.com/conditions/breast-neoplasms)

## Mechanism of action

Breast cancer cell growth may be estrogen-dependent. Aromatase is the principal enzyme that converts androgens to estrogens both in pre- and postmenopausal women.

## Drug classification

- Established Pharmacologic Class: Aromatase Inhibitor [EPC]
- Mechanism of Action class: Aromatase Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

mild to moderate and included hot flushes (13% vs

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)